Cargando…
DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway
SIMPLE SUMMARY: Ferroptosis exhibits potent antitumor ability and dihydroorotate dehydrogenase (DHODH) has recently been identified as a novel ferroptosis defender independently of GPX4 or FSP1. DHODH has been studied in several diseases including oral squamous cell carcinoma and small cell lung can...
Autores principales: | Jiang, Mengying, Song, Yizuo, Liu, Hejing, Jin, Yanshan, Li, Ruyi, Zhu, Xueqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856746/ https://www.ncbi.nlm.nih.gov/pubmed/36672495 http://dx.doi.org/10.3390/cancers15020546 |
Ejemplares similares
-
PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer
por: Zhu, Haiyan, et al.
Publicado: (2016) -
METTL3 increases cisplatin chemosensitivity of cervical cancer cells via downregulation of the activity of RAGE
por: Li, Ruyi, et al.
Publicado: (2021) -
The Warburg effect modulates DHODH role in ferroptosis: a review
por: Amos, Alvan, et al.
Publicado: (2023) -
Effects of Galectin-1 on Biological Behavior in Cervical Cancer
por: Chetry, Mandika, et al.
Publicado: (2020) -
The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells
por: Xue, Fang, et al.
Publicado: (2019)